The Peptide NewsroomPeptide research, industry and supply-chain headlines

South Carolina Woman Reports Skin Discoloration After Ordering Peptides Online, Doctor Urges Caution

Topic card: fda

A Greenville woman told FOX Carolina she noticed dark spots on her skin after ordering peptides and NAD+ online. Ashley Sams said the discoloration appeared around her neck, back, stomach and legs after she started the products, which a friend had introduced her to.

Sams said she ordered melanotan, a peptide that can lead to darkening of the skin or a tan without UV exposure, along with retatrutide for weight loss and NAD+ for energy. She said she only became concerned once other people started commenting on how her skin looked. "I feel like the melanotan, it didn't make me tan; it made me orange," she told the station.

Three products at once

Sams also reported shortness of breath, and said she does not know which product caused it because she took all of them at the same time. That is the part worth sitting with: taking three unregulated compounds simultaneously makes it close to impossible for anyone, including her doctor, to work out what did what.

Dr. Jonathan Leake of Hydrate Medical in Charlotte, speaking about NAD+ therapy on The Wellness Files with Kari Beal podcast, said the compound is supposed to be administered over several hours because too much at once can cause side effects, and that for some people that could include shortness of breath.

What her doctor said

Sams went to her family physician, Dr. Nita Bijoor of Oakview Medical Associates, who said no medical professional was involved in the purchases. Bijoor called buying a peptide online without knowing its purity "extremely concerning," and noted that many of these vials carry research-only labeling: "A lot of them actually will say not for human use."

Bijoor told Sams to stop taking all peptides immediately and wants her to see a dermatologist. None of the items Sams ordered are FDA-approved, and they are not tested or regulated by a medical organization, which means there is no assurance of what a given vial actually contains.

The compounding policy does not cover this

A recent government policy allows pharmacies to compound six peptides, and some hope it will make those compounds safer than research-only products bought online. The policy does not make them FDA-approved, and the peptides Sams ordered are not among the six.

Bottom line

Doctors told the station that pharmacy compounding does not by itself make these peptides safe, and researchers say most of the data come from animal studies with few human clinical trials performed. Sams' own advice was blunter: "Even the reviews can be fake. I would say talk to your doctor about it first; I wish I had."

Source: RSS.app — Peptides bundle. Read the original.

Filed under: fda, skin-beauty

Comments (0)

Discussion happens on Reddit.
Questions and corrections go to r/PeptideNewsroom.

Go to r/PeptideNewsroom

Corrections are the most useful thing you can post. Comments touching dosing, sourcing or links are held for a moderator first.

More from The Peptide Newsroom

Sermorelin Goes Mainstream on Telehealth, but the Dosing and Efficacy Data Are Missing

Sermorelin, a peptide that stimulates growth-hormone release, is now sold nationally through Hims and Hers as part of its compounded Peptides+ platform. Neither the company nor the outside experts quoted can point to human outcome trials or an established dose.

Karnataka Regulators Cancel a Bengaluru Peptide Party as India's Longevity Market Accelerates

Karnataka's drug regulator canceled a Bengaluru "Peptide Party" on August 29 and questioned the organizers about ingredients, legality and health claims. The Indian Express reports the shutdown against a biohacking market Grand View Research valued at $1.21 billion in 2025.

FDA's Peptide Compounding Shakeup Blurs Drug and Supplement Lines, and Legitimate Brands Are Exposed

New Hope Network reports that FDA's shifting peptide compounding rules have left gray-market injectables like BPC-157 and TB-500 in regulatory limbo, while some supplement brands sell them under a Supplement Facts panel. Industry lawyers call that illegal, and legitimate peptide brands may pay the reputational bill.